A schematic diagram of the development of next-generation RNA gene editing technology using induction evolution The Catholic ...

Conventional treatment for Parkinson's disease often involves the drug levodopa, which is used to replace dopamine in the brain that has been lost because of the disorder.

About five years ago, Krehbiel and McElroy volunteered for an innovative non-pharmacological treatment for Parkinson’s disease, called adaptive deep brain stimulation.

Using an innovative diagnostic method that could transform early detection, scientists at Zhejiang University achieved a ...

NEW HAVEN, Conn. (WTNH) — People with Parkin’s disease can have debilitating symptoms despite the best medical care. Thankfully, research is robust and new treatment options are on the horizon.

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced Parkinson's disease, Supernus Pharmaceuticals announced on Tuesday.. The ...

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

Scientists have finally pinned down a protein that’s largely responsible for Parkinson’s disease. Known as PINK1, the protein has been linked to the disease for decades but its structure and ...

Dr. Helen Bronte-Stewart developed adaptive Deep Brain Stimulation (aDBS) as a more responsive and refined treatment for the symptoms of Parkinson’s Disease - the FDA approved aDBS for the ...

Vyalev offers patients a steady flow of dopamine to counter the tremors associated with the disease Last Updated: Oct. 17, 2024 at 11:34 a.m. ET First Published: Oct. 17, 2024 at 8:12 a.m. ET Share ...

As symptoms progress, people with Parkinson’s disease may struggle to walk, speak and carry out other basic tasks. An estimated three-quarters of people living with Parkinson’s for more than ...